In Situ Encapsulation of Biologically Active Ingredients into Polymer Particles by Polymerization in Dispersed Media

13 September 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


The encapsulation of biologically active ingredients (e.g., peptides, proteins, enzymes, drugs) into polymer particles is extensively used for drug delivery purposes. However, this strategy relies mainly on emulsification processes from preformed polymers, which leads to strong limitations such as low particle concentrations (typically a few wt %), poor active ingredient loadings, as well as a rather limited structural diversity of the polymers usually used. Conversely, polymerizations in dispersed media, which allow for the formation of scalable suspensions of (nano)particles during the polymerization process, have been advantageously used for the in situ encapsulation of active ingredients. In this review, the in situ encapsulation of active ingredients, such as peptides, proteins, enzymes or drugs, in polymer particles obtained by polymerization in dispersed media for potential biomedical applications, is covered. Their physical and chemical encapsulations were both considered as function of the polymerization technique used. Several polymerization and encapsulation parameters will be discussed in view of adjusting the drug loading and the encapsulation efficiency of the active agent considered.


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.